DenseBreast-info, Inc.

State Insurance Law A new Massachusetts insurance law requiring no-cost coverage for screening and diagnostic imaging (exemptions apply) will go into effect on 1/1/2026. For more details, see DBI’s?State Law Insurance Map?and?Table, available here: https://lnkd.in/gmM3dGBH ? RANZCR Position Statement? The Royal Australian and New Zealand College of Radiologists have issued an updated?Breast Density Position Statement – Why Reporting Matters.?According to the statement, “RANZCR supports the inclusion of breast density reporting in all mammographic assessments. This move aligns with the growing global recognition of the importance of breast density in breast cancer screening. In countries like the USA, it is already mandatory to report breast density in mammograms, and similar practices are being considered in Europe.” Read here: https://lnkd.in/g-CgcgWu ? New Study A study by Gjesvik and colleagues examined whether a commercially available AI algorithm for breast cancer detection could also estimate risk for future breast cancer development. This retrospective cohort study included 116,495 women aged 50-69 years who underwent at least 3 consecutive biennial mammography screening rounds in Norway. The study found that the AI algorithm for cancer detection was able to estimate future breast cancer risk 4-6 years before diagnosis. Specifically, compared to women who did not develop breast cancer[1],?the study found: ? The mean absolute difference in AI scores between breasts of women who developed screen-detected cancer or interval cancer was greater at each round and increased over the three rounds [2,3]. These results suggest that AI scores for cancer detection may be used to identify women at high risk of developing cancer who may benefit from supplemental screening. ? 1. A cancer detection score of 0-100 was given to each breast. The mean (SD) absolute differences in AI scores between breasts of women who did not develop breast cancer were? 9.9 (17.5),? 9.6 (17.4), and 9.3 (17.3) at the first, second, and third screening rounds, respectively. 2. Scores were higher in breasts that developed cancer, and this was compared to the noncancerous breast. The mean (SD) absolute differences in AI scores between breasts of women who developed screen-detected cancer in one breast and not the other were 21.3 (28.1), 30.7 (32.5), and 79 (28.9) at the first, second, and third screening rounds, respectively. 3. The mean (SD) absolute differences in AI scores between breasts of women who developed interval cancer in one breast and not the other were 19.7 (27.0), 21.0 (27.7), and 34.0 (33.6) at the first, second, and third screening rounds, respectively. Full study available here: https://lnkd.in/griZwA69

Patient Fact Sheet NEW! Our popular and printable dense breast?Patient Fact Sheet, already translated into?25+ languages, is now available in Albanian. All languages available here: https://lnkd.in/dfCMPf2U ? New Study A recent study by DBI Medical Advisory Board member Jean Seely, MD and colleagues?assessed differences in breast cancer incidence, mortality, stage, and molecular subtypes by race/ethnicity among women aged 20 and older in Canada. The analysis of linked Canadian Cancer Registry (CCR) and census data found that compared to white women, women from other race/ethnicity groups: ? Had earlier peak age at diagnosis ? Were more likely to have a more advanced stage at diagnosis ? Were more likely to have molecular subtypes with poorer outcomes In addition, compared to white women, black and indigenous women had higher breast cancer mortality. These data suggest race/ethnicity-based health care inequities that should be considered in Canadian Breast cancer screening and health care policies. Full study available here: https://lnkd.in/g936m-ay

When a patient comes back to hug you, you know you've done your best. We salute #RadTechs and their dedication to patient care. Watch "A Mammographer's Story" now: https://lnkd.in/gbQ-Aifz #ThankYou #NRTW24

NEW!?Now that the FDA?dense breast reporting standard is in effect, DBI has retired its “State Inform Law Map" (however, the map is still available upon request). ? As the next focus is insurance coverage for supplemental screening, DBI has launched a new interactive?"State Law Insurance Map." The map tracks breast imaging insurance coverage by state, and a corresponding State Law Insurance Table is also available. ? Visit the ”Insurance/Inform Laws” tab for individual links to: ? ? Federal: FDA Dense Breast Reporting ? State Law Insurance Map ? State Law Insurance Table ? Federal Insurance Bill: Find It Early Act? Find it all here: https://lnkd.in/ghU4y3B

NEW!?Now that the FDA?dense breast reporting standard is in effect, DBI has retired its “State Inform Law Map" (however, the map is still available upon request). ? As the next focus is insurance coverage for supplemental screening, DBI has launched a new interactive?"State Law Insurance Map." The map tracks breast imaging insurance coverage by state, and a corresponding State Law Insurance Table is also available. ? Visit the ”Insurance/Inform Laws” tab for individual links to: ? ? Federal: FDA Dense Breast Reporting ? State Law Insurance Map ? State Law Insurance Table ? Federal Insurance Bill: Find It Early Act? Find it all here: https://lnkd.in/ghU4y3B

Risk Model Tutorial? A resource reminder! DBI’s?Risk Model Tutorial?content for health care providers includes: ?? How the models are used ?? Risk model explanations ?? Diagnostic considerations ?? Risk models table (with live links) Available here: https://lnkd.in/giY68Sdz ? New Study At Rush University affiliated centers in Chicago, a retrospective review of?automated breast ultrasound (ABUS) use in women with dense breasts was conducted. DBI has the summary available here: https://lnkd.in/gXtiK77y

Who Needs More Screening? Flowchart This popular screening decision support tool for health providers has just been updated, view it?here: https://lnkd.in/dg2h6cui ? CEM Study A retrospective, single-institution?study at Memorial Sloan Kettering Cancer Center?reported results of several rounds of screening contrast-enhanced mammography (CEM) in 609 women with extremely dense breasts, most of whom also had other risks for breast cancer. DBI has provided a summary, available here: https://lnkd.in/gwfGw_Yc

2024 #WorldDenseBreastDay Success Story: 1. We had participation from people in 104 (!) countries 2. Over 16.8 million people saw/read the posts 3. Over 51,200 people interacted with the posts by liking, or sharing ? New York State Insurance Law New York has amended its breast imaging insurance law to require certain insurance policies to allow patients additional screenings for breast cancer when the provider deems such screening is necessary under nationally recognized clinical practice guidelines. Please see DBI’s?Insurance/Inform Laws?tab for more details: https://lnkd.in/ghU4y3B

#WorldDenseBreastDay Analytics While still waiting for final analytics to come in for #WorldDenseBreastDay, 2024 participation will break previous records! And, it was indeed a world event - we had participants from?70+ countries.?Thank you to all that participated! ? Find It Early Act The U.S. bipartisan bill for expanded no-cost insurance coverage after a mammogram introduced in the House (HR3086) now has a?Senate companion bill?(S5141). Many thanks to co-sponsors Reps. Rosa DeLauro (D), Brian Fitzpatrick (R), and Sens. Amy Klobuchar (D), Roger Marshall (R). See?Find It Early Act?for updates and lobbying tools: https://lnkd.in/grrrA3S5.?? EUSOBI?2024, Oct 3-5 The European Society of Breast Imaging Annual Scientific Meeting takes place 3 - 5 October in Lisbon.?The?https://lnkd.in/esmYp4Vu?exhibition stand will be located at R4.?Please Visit! Cheryl Cruwys, DBI’s European Education Coordinator, will be there, and Executive Director JoAnn Pushkin will be at the booth on Friday the 4th.

It’s #WorldDenseBreastDay. Let’s talk about what's on the horizon: ? The Find It Early Act will be re-introduced in the next Congress. Based on insights garnered from our Capitol Hill Congressional office visits, we will again be offering input on the language of the legislation. ? Individual state insurance laws will continue to be introduced, many with “no cost sharing” provisions. ? Based on the “real world” reactions to the FDA’s notification rule, DBI is poised and ready to fill the need for additional educational tools if needed for patients and health providers. Growing from 40,000 visits in 2016, DenseBreast-info.org projects over one million visits in 2024.